Pharmaceutical compositions comprising calcitonin for intranasal administration
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 7, 1996
Issued Date -
N/A
app pub date -
Apr 25, 1994
filing date -
Oct 11, 1988
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method for treating a patient suffering from any of osteoporosis, Paget's disease and hypercalcemia by intranasally administering to said patient by spray a calcitonin solution consisting of calcitonin dissolved in a 0.9% aqueous sodium chloride solution free of quaternary ammonium compounds and surfactants, the calcitonin being in a concentration of 100-5000 IU per ml. of composition.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully